ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Services Research"

  • Abstract Number: 0063 • ACR Convergence 2022

    Implementability of a SLE Medication Adherence Intervention

    Kai Sun1, Nneka Molokwu2, Amy Corneli1, Kathryn Pollak1, Alexandria Bennion2, Jennifer L Rogers3, Rebecca Sadun2, Lisa Criscione-Schreiber1, Jayanth Doss2, Amanda Eudy4, Hayden Bosworth1 and Megan Clowse2, 1Duke University School of Medicine, Durham, NC, 2Duke University, Durham, NC, 3Duke University School of Medicine, Division of Rheumatology & Immunology, Durham, NC, 4Duke University, Raleigh, NC

    Background/Purpose: Medication nonadherence in SLE is common and negatively impacts patient outcomes. Yet, little is known about how to improve medication adherence in patients with…
  • Abstract Number: 0104 • ACR Convergence 2022

    Gender Representation of the Editors and Editorial Boards of the Top 45 Rheumatology-Focused Journals

    Aldo Barajas-Ochoa1, Amaranta ManriquedeLara2, Alfonso Gastelum-Strozzi3, Ingris Pelaez-Ballestas4, Antonio Cisneros-Barrios5, Manuel Ramirez-Trejo5, Paloma Gradilla-Magaña5 and Cesar Ramos-Remus6, 1Rutgers New Jersey Medical School., Richmond, VA, 2Hospital General de México "Dr. Eduardo Liceaga,", Ciudad de México, Mexico, 3Universidad Nacional Autónoma de México, Ciudad de México, Mexico, 4Hospital General de México "Dr. Eduardo Liceaga", Ciudad de México, Mexico, 5Universidad de Guadalajara, Guadalajara, Mexico, 6Unidad de Investigacion en Enfermedades Cronico-Degenerativas, Guadalajara, Mexico

    Background/Purpose: The assessment of the frequency distribution of females and males is occurring in different academic areas. Academic publishing is not exempt from potential structural…
  • Abstract Number: 0862 • ACR Convergence 2022

    Impact of the COVID-19 Pandemic on the Management of Juvenile Idiopathic Arthritis: An Analysis of National United States Administrative Claims Data

    Daniel Horton1, Yiling Yang2, Amanda Neikirk2, Cecilia Huang3, Stephen Crystal4, amy davidow5, Kevin Haynes6, Tobias Gerhard7, Carlos Rose8, Brian Strom9 and Lauren Parlett2, 1Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, 2HealthCore, Wilmington, DE, 3Rutgers Center for Pharmacoepidemiology and Treatment Science, New Brunswick, NJ, 4Rutgers Center for Health Services Research, New Brunswick, NJ, 5New York University, New York, NY, 6Johnson & Johnson, Titusville, NJ, 7Ernest Mario School of Pharmacy, Rutgers University, New Brunswick, NJ, 8Nemours, Chadds Ford, PA, 9Rutgers Biomedical and Health Sciences, Newark, NJ

    Background/Purpose: Limited information exists on COVID-19 pandemic-related changes in the management of rheumatic diseases in adults or children, besides what patients and families have reported.…
  • Abstract Number: 2198 • ACR Convergence 2022

    How Did a Mandatory Switching Policy for Biosimilars in Canada Impact Uptake and Spending?

    Alison McClean1, Nick Bansback1, Lucy Cheng1, Fiona Clemont2, Mina Tadrous3, Mark Harrison1 and Mike Law1, 1University of British Columbia, Vancouver, BC, Canada, 2University of Calgary, Calgary, AB, Canada, 3University of Toronto, Toronto, ON, Canada

    Background/Purpose: Uptake of biosimilars has been suboptimal in North America. In 2019, British Columbia (BC) became the first jurisdiction in North America to require patients…
  • Abstract Number: 0066 • ACR Convergence 2022

    Identifying Childhood-Onset Systemic Lupus Erythematosus, Lupus Nephritis, and End-Stage Kidney Disease Definitions Within an Administrative Claims Database

    Emily Smitherman1, Rouba Chahine1, Aimee Hersh2 and Jeffrey Curtis3, 1University of Alabama at Birmingham, Birmingham, AL, 2University of Utah, Salt Lake City, UT, 3University of Alabama at Birmingham, Hoover, AL

    Background/Purpose: Data is lacking regarding modern real-world practices and disease outcomes of individuals with childhood-onset systemic lupus erythematosus (cSLE) and lupus nephritis, especially across multiple…
  • Abstract Number: 0118 • ACR Convergence 2022

    Sex-Based Variations in Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions

    Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Katie Lin1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Eileen Davidson3, Clare Hildebrandt4, Steven Katz2, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

    Background/Purpose: High quality ambulatory care provision should mitigate avoidable emergency department (ED) visits by persons with inflammatory arthritis (IA) conditions and address the unique realities…
  • Abstract Number: 1224 • ACR Convergence 2022

    ‘No Route Map’: The Complex Healthcare Journeys of People with Fibromyalgia – a Record Linkage Study in the UK

    Rosemary Hollick, Ka-Kin Lam, Marcus Beasley, Gareth Jones, Corri Black and Gary Macfarlane, University of Aberdeen, Aberdeen, Scotland, United Kingdom

    Background/Purpose: Healthcare services for persons with fibromyalgia (FM) lack co-ordination. Patients describe feeling 'invisible' within healthcare systems and often report poor experiences of care, particularly…
  • Abstract Number: 0067 • ACR Convergence 2022

    Cost Per Responder in RA Patients Failing First Line Treatment

    Manuel Cardozo, Pharmalab PHL, Huixquilucan, Mexico

    Background/Purpose: The Colombian healthcare system is under economic pressure like many other systems in the world. In that sense, treatment choice involves cost in addition…
  • Abstract Number: 0119 • ACR Convergence 2022

    Emergency Department Utilization by Persons with Inflammatory Arthritis Conditions Varies by Geographic Location of Residence

    Cheryl Barnabe1, Patrick McLane2, Nadia Luca1, Kelsey Chomistek1, Meghan Elliott1, Shanon McQuitty3, Steven Katz2, Eileen Davidson3, Clare Hildebrandt4, Katie Lin1, Brian Holroyd2 and Claire Barber1, 1University of Calgary, Calgary, AB, Canada, 2University of Alberta, Edmonton, AB, Canada, 3Arthritis Research Canada, Vancouver, BC, Canada, 4Patient and Family Advisors, Alberta Health Services, Calgary, AB, Canada

    Background/Purpose: Rheumatology services in Canada are largely restricted to urban centres, resulting in significant access difficulties for residents of rural and remote locations. As a…
  • Abstract Number: 1272 • ACR Convergence 2022

    Application of the Consolidated Framework for Implementation Research (CFIR) to Study Top-Performing Practices in the RISE Registry

    Lindsay Jacobsohn1, Catherine Nasrallah2, Cammie Young3, Gabriela Schmajuk4 and Jinoos Yazdany5, 1University of California, San Francisco, San Francisco, CA, 2UCSF, San Francisco, 3University of California San Francisco, San Francisco, CA, 4UCSF / SFVA, San Francisco, CA, 5UCSF, San Francisco, CA

    Background/Purpose: Collection and use of rheumatoid arthritis (RA) disease activity and functional status outcome measures facilitates treating-to-target and shared decision-making. Although guidelines recommend regular use…
  • Abstract Number: 0145 • ACR Convergence 2021

    Rheumatology Provider Perspectives on Using Patient-Reported Outcomes in Clinical Care

    Yomei Shaw1, Neda Kortam2, Adam Chalak2, Yujia Li2, Faith Reger2, Vivek Nagaraja2 and Dinesh Khanna2, 1University of Michigan, East Lansing, MI, 2University of Michigan, Ann Arbor, MI

    Background/Purpose: Patient-reported outcomes (PROs) are surveys completed by patients to provide measurements of health, quality of life, symptoms, and functional status. PROs are useful for…
  • Abstract Number: 1073 • ACR Convergence 2021

    In Favor of the Subspecialty Clinic Model for Rheumatoid Arthritis

    Jasmine Thai1, Roshan Patel1, Yeohan Song1 and Sheryl Mascarenhas2, 1Ohio State University, Columbus, OH, 2Ohio State University Hospital, Columbus, OH

    Background/Purpose: The Subspecialty Clinic Model (SCM) which seeks to allow for collaborative care and services by stratifying patients with a particular disease or need to…
  • Abstract Number: 0148 • ACR Convergence 2021

    Implementation of an Interprofessional Safety Check to Screen for Latent Tuberculosis at an Academic Tertiary Referral Rheumatology Clinic Increased Screening Rates Compared to Historical Levels

    Meera Subash, Hailyn Nielsen, Neda Noori Nassr, Diana Ung and Andrew Gross, University of California San Francisco, San Francisco, CA

    Background/Purpose: Certain disease-modifying anti-rheumatic drugs (DMARDs) increase the risk of reactivation of latent tuberculosis (TB). While screening for latent TB prior to initiation of these…
  • Abstract Number: 1075 • ACR Convergence 2021

    The Impact of an Integrated Care Management Program on Acute Care Use for Potentially Avoidable Conditions Among High-Risk Patients with SLE

    Jessica Williams1, Kreager Taber1, Weixing Huang1, Jamie Collins1, Rebecca Cunningham1, Katherine Concannon1, Christine Vogeli2, Lisa Wichmann1 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA

    Background/Purpose: Patients with SLE are disproportionately from populations with lower socioeconomic status and poorer access to health care, placing them at risk for potentially avoidable…
  • Abstract Number: 0154 • ACR Convergence 2021

    Utilization of Magnetic Resonance Imaging in Early Rheumatoid Arthritis: Results from a Population-based Cohort (1999-2014)

    Caitrin Coffey1, Cynthia Crowson2, Cassondra Hulshizer1, Gavin McKenzie1, Nicholas Rhodes1, John Davis1 and Kerry Wright1, 1Mayo Clinic, Rochester, MN, 2Mayo Clinic, Eyota, MN

    Background/Purpose: Early diagnosis and treatment initiation improve outcomes for patients with rheumatoid arthritis (RA). Delays to diagnosis and treatment affect patients with seronegative vs seropositive…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 18
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology